ºÝºÝߣ

ºÝºÝߣShare a Scribd company logo
Brucellosis

     Dr. Ali Jabari
      Senior Family Physician
      F.I.B.M.S-FM, M.B.Ch.B
         Slemani University
Identification
 Zoonotic
 world-wide
 highest incidence in the Mediterranean, ME
 and the tropics
 500 000 new cases diagnosed per year.
 In humans, is a disease of protean
 manifestations
 biological terrorism.
Infectious agent

 • Brucella abortus
 • Brucella melitensis
 • Brucella suis
 • Brucella canis
Epidemiology
 In animals; chronic lifelong  infectious
 abortion and sterility.
 Infected animals  milk, urine, afterbirth.
 Occupational hazard  farmers, ranchers,
 veterinarians, abattoir workers, and
 laboratory personnel.
• incidence varies 
           _control in domestic animal
           _pasteurization
• Common  SE, ME, the Indian
  subcontinent, Africa, and Central and South
  America.
• Infection ; ingestion of unpasteurized milk
  products from foreign countries.
Reservoir
_Animal reservoirs
Mode of transmission
  contact with infected tissues, blood, urine,
 vaginal discharges, aborted animal fetuses
 and especially placentae.
 ingestion of raw milk and dairy products
 from infected animals.
 inhalation of aerosols
 accidental self-inoculation
 abrasions, cuts, conjunctiva.
 BM transplantation recently.
Incubation period
varies from 5-60 days;
occasionally several months.
Clinical features
 Systemic
 acute or insidious
 Subclinical and unrecognized infections
 fever
 Localised suppurative infections
 Osteoarticular complications
 Orchitis, epididymitis, osteomyelitis and
 endocarditis are less common.
CFR in untreated brucellosis is 2%, mostly
due to endocarditis from B. melitensis
infections.
Arthritis may occur in relapse
Diagnosis
 Culture  blood, BM, other tissues or
 discharges.
 Serology combine a test (Rose Bengal and
 seroagglutination) detecting agglutinating
 antibodies (IgM, IgG and IgA) with others
 detecting nonagglutinating antibodies
 (Coombs-IgG or ELISA-IgG).
 Except in the case of B. canis, Ab to
 lipolysaccharide Ag.
Period of
communicability
 There is no evidence of communicability
 from person to person.
Susceptibility & resistance
 Everyone is susceptible to infection.
 Severity and duration of clinical illness are
 subject to wide variation.
 Duration of acquired immunity is uncertain.
 People at risk are farmers, hunters, and
 eaters of unpasteurized cheeses or other
 unpasteurized dairy products.
Methods of control
__Preventive measures:
  Educate the public, particularly travellers,
  Educate risky group
  Search for and Ix livestock at risk of
  infection.
  Segregation or slaughtering of infected
  herd.
  Animal vaccination
__Control of patients, contacts and immediate
  environment:
  Report to LHA
  Isolation
  Concurrent disinfection: purulent discharge.
  Quarantine: none.
  Immunization of contacts: none.
  Investigation of contacts and source of
  infection: contact tracing
  S&S
Specific treatment:

a) D+R, or D+G or S for 6 weeks.
b) TS+R children.
c) meningitis or endocarditis, D+R+TS must
  be continued for months or years.
   d) Never use a single drug (high risk of
  relapse).
   e) Relapses occur in about 5% of patients
  treated with D and R; re-treat with original
  regimen.
Outbreak measures: Trace source of
infection such as contaminated
unpasteurised milk products and institute
appropriate control measures.
International measures: Control of domestic
animals and animal products in international
trade and transport
Brucellosis by dr.ali jabari

More Related Content

Brucellosis by dr.ali jabari

  • 1. Brucellosis Dr. Ali Jabari Senior Family Physician F.I.B.M.S-FM, M.B.Ch.B Slemani University
  • 2. Identification Zoonotic world-wide highest incidence in the Mediterranean, ME and the tropics 500 000 new cases diagnosed per year. In humans, is a disease of protean manifestations biological terrorism.
  • 3. Infectious agent • Brucella abortus • Brucella melitensis • Brucella suis • Brucella canis
  • 4. Epidemiology In animals; chronic lifelong  infectious abortion and sterility. Infected animals  milk, urine, afterbirth. Occupational hazard  farmers, ranchers, veterinarians, abattoir workers, and laboratory personnel.
  • 5. • incidence varies  _control in domestic animal _pasteurization • Common  SE, ME, the Indian subcontinent, Africa, and Central and South America. • Infection ; ingestion of unpasteurized milk products from foreign countries.
  • 7. Mode of transmission contact with infected tissues, blood, urine, vaginal discharges, aborted animal fetuses and especially placentae. ingestion of raw milk and dairy products from infected animals. inhalation of aerosols accidental self-inoculation abrasions, cuts, conjunctiva. BM transplantation recently.
  • 8. Incubation period varies from 5-60 days; occasionally several months.
  • 9. Clinical features Systemic acute or insidious Subclinical and unrecognized infections fever Localised suppurative infections Osteoarticular complications Orchitis, epididymitis, osteomyelitis and endocarditis are less common.
  • 10. CFR in untreated brucellosis is 2%, mostly due to endocarditis from B. melitensis infections. Arthritis may occur in relapse
  • 11. Diagnosis Culture  blood, BM, other tissues or discharges. Serology combine a test (Rose Bengal and seroagglutination) detecting agglutinating antibodies (IgM, IgG and IgA) with others detecting nonagglutinating antibodies (Coombs-IgG or ELISA-IgG). Except in the case of B. canis, Ab to lipolysaccharide Ag.
  • 12. Period of communicability There is no evidence of communicability from person to person.
  • 13. Susceptibility & resistance Everyone is susceptible to infection. Severity and duration of clinical illness are subject to wide variation. Duration of acquired immunity is uncertain. People at risk are farmers, hunters, and eaters of unpasteurized cheeses or other unpasteurized dairy products.
  • 14. Methods of control __Preventive measures: Educate the public, particularly travellers, Educate risky group Search for and Ix livestock at risk of infection. Segregation or slaughtering of infected herd. Animal vaccination
  • 15. __Control of patients, contacts and immediate environment: Report to LHA Isolation Concurrent disinfection: purulent discharge. Quarantine: none. Immunization of contacts: none. Investigation of contacts and source of infection: contact tracing S&S
  • 16. Specific treatment: a) D+R, or D+G or S for 6 weeks. b) TS+R children. c) meningitis or endocarditis, D+R+TS must be continued for months or years. d) Never use a single drug (high risk of relapse). e) Relapses occur in about 5% of patients treated with D and R; re-treat with original regimen.
  • 17. Outbreak measures: Trace source of infection such as contaminated unpasteurised milk products and institute appropriate control measures. International measures: Control of domestic animals and animal products in international trade and transport